Similar Search Results

The effects of drug market regulation on pharmaceutical prices in Europe : overview and evidence from the market of ACE inhibitors

Schulenburg, Fritz von der; Vandoros, Sotiris; Kanavos, … - In: Health economics review 1 (2011) 18, pp. 1-8

This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices. Panel data methods are used to examine the market of ACE Inhibitors in six European countries (Denmark, France, Germany, Netherlands,...

Persistent link: https://www.econbiz.de/10009503923

The generics paradox revisited : empirical evidence from regulated markets

Vandoros, Sotiris; Kanavos, Panos - In: Applied economics 45 (2013) 22/24, pp. 3230-3239

Persistent link: https://www.econbiz.de/10010345456

Pharmaceutical parallel trade in Europe : stakeholder and competition effects

Kanavos, Panos; Costa-Font, Joan - In: Economic policy : a European forum 44 (2005), pp. 751-798

Persistent link: https://www.econbiz.de/10011517376

Parallel trade and pharmaceutical prices : a game-theoretic approach and empirical evidence from the European Union

Vandoros, Sotiris; Kanavos, Panos - In: The world economy : the leading journal on … 37 (2014) 6, pp. 856-880

Persistent link: https://www.econbiz.de/10010469924

¿A quién beneficia el comercio paralelo de medicamentos en la Unión Europea?

Costa-Font, Joan; Kanavos, Panos - In: El trimestre económico 76 (2009) 2, pp. 331-347

Persistent link: https://www.econbiz.de/10003841132

Impact and costs of pharmaceuticlas and biotechnology

Kanavos, Panos - 2016

Persistent link: https://www.econbiz.de/10011480766

Pharmaceutical parallel trade in the UK

Kanavos, Panos; Holmes, Paula - 2005

Persistent link: https://www.econbiz.de/10002817524

Macroeconomic constraints and health challenges facing European health systems

Kanavos, Panos; McKee, Martin - In: Critical challenges for health care reform in Europe, (pp. 23-52). 1998

Persistent link: https://www.econbiz.de/10001304568

Reference pricing for drugs : is it compatible with US health care?

Kanavos, Panos; Reinhardt, Uwe E. - In: Health affairs : at the intersection of health, health … 22 (2003) 3, pp. 16-30

Persistent link: https://www.econbiz.de/10001767920

Multi-criteria decision analysis for health technology assessment : addressing methodological challenges to improve the state of the art

Oliveira, Mónica Duarte; Mataloto, Inês; Kanavos, Panos - In: The European journal of health economics : HEPAC ; … 20 (2019) 6, pp. 891-918

Persistent link: https://www.econbiz.de/10012061325